New in brief

HPCTC launches renal impairment clinical study offering

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Natali_Mis)
(Image: iStock/Natali_Mis)

Related tags: Pharmacology

High Point Clinical Trials Center (HPCTC) is now offering renal impairment clinical studies.

HPCTC conducts early-stage clinical pharmacology studies in healthy volunteers and proof of concept studies in a range of patient populations and is the largest commercial clinical research unit in North Carolina.

According to the company, the expanded service offering comes in response to an increasing demand from the pharmaceutical industry to understand the pharmacokinetic impact of novel drugs in renally compromised patients.

Additionally, HPCTC has contacted local nephrologists who will contribute to medical oversight and patient management.

In February of last year, the company also partnered with Verified Clinical Trials​ to help prevent duplicate enrollment in trials.

Related topics: Clinical Development

Related news

Show more

Follow us

Products

View more

Webinars